These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12797662)

  • 1. Oracles, plagues, and sound bites.
    Meyer CR
    Minn Med; 2003 Apr; 86(4):68. PubMed ID: 12797662
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of hs-CRP measurements in the current cardiovascular risk assessment.
    Levinson SS; Elin RJ
    Clin Chim Acta; 2005 Jun; 356(1-2):225-6. PubMed ID: 15936322
    [No Abstract]   [Full Text] [Related]  

  • 3. CRP as a marker for cardiovascular risk.
    Savill P
    Practitioner; 2008 Dec; 252(1713):4. PubMed ID: 19192697
    [No Abstract]   [Full Text] [Related]  

  • 4. [Emerging risk factors for cardiovascular disease].
    Demant T
    Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
    [No Abstract]   [Full Text] [Related]  

  • 5. Health screening packages: the place of measuring C-reactive protein.
    Wong MS
    Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955
    [No Abstract]   [Full Text] [Related]  

  • 6. C-reactive protein and cardiovascular risk in the Framingham Study.
    Ridker P; Rifai N; Koenig W; Blumenthal RS
    Arch Intern Med; 2006 Jun; 166(12):1327-8; author reply 1328. PubMed ID: 16801524
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein: a new risk assessment tool for cardiovascular disease.
    Clearfield MB
    J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hs-CRP measurements in the current cardiovascular risk assessment.
    García-Moll X; Ordóñez-Llanos J
    Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and cardiovascular disease: are we looking in the right direction?
    Hashimoto J; O'Rourke MF
    J Hypertens; 2006 Oct; 24(10):2115. PubMed ID: 16957575
    [No Abstract]   [Full Text] [Related]  

  • 13. C-reactive protein and coronary heart disease.
    Foody JM; Gotto AM; Wenger N
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
    [No Abstract]   [Full Text] [Related]  

  • 14. Getting journalists up to speed.
    Voss M
    Minn Med; 2003 Apr; 86(4):20-1, 47. PubMed ID: 12797653
    [No Abstract]   [Full Text] [Related]  

  • 15. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between protein-bound sialic acid and high-sensitivity C-reactive protein in essential hypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Nandeesha H; Selvaraj N; Bobby Z; Agrawal A; Pavithran P
    Angiology; 2008 Dec-2009 Jan; 59(6):721-6. PubMed ID: 18388037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds.
    Dotsenko O; Chackathayil J; Lip GY
    J Hypertens; 2008 Jan; 26(1):11-3. PubMed ID: 18090533
    [No Abstract]   [Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical application of C-reactive protein in prognosis and prevention of cardiovascular disease].
    Feng RF
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1370-3. PubMed ID: 14584491
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.